BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Parascript Enters Medical Imaging Breast Cancer Detection Market


11/14/2007 7:27:39 AM

BOULDER, Colo., Nov. 14 /PRNewswire/ -- Parascript, LLC, the image analysis and pattern recognition technology provider, today announced its entrance into the medical imaging market. With over a dozen years experience in image analysis and a history of best-in-class products that surpass established industry benchmarks, the company expanded its product suite to include computer-aided detection (CAD) algorithms to detect breast cancer.

Parascript AccuDetect is intended to help radiologists in the early detection of breast cancer during film-based or digital mammography exams. AccuDetect is a set of computer-aided detection algorithms designed to deliver the lowest false positive rates in the industry. High false-positive rates have been a major problem in the CAD industry resulting in increased patient call-back levels, unnecessary expense, patient anguish and pain. Parascript anticipates that existing false-positive rates can be reduced by 60 to 80 percent with the use of AccuDetect algorithms.

"With an established track record of accurately extracting and interpreting meaningful information from images in numerous markets, Parascript is proud to employ our proprietary algorithms designed to detect hard to find cancers while reducing false-positives, thereby increasing the quality of patient care," said Jeff Gilb, president and CEO of Parascript. "We look forward to working with leading providers of mammography systems in this space to raise the bar in accurately detecting breast cancer and improving women's healthcare."

AccuDetect utilizes Parascript's image analysis and recognition technology to automatically identify and clearly mark suspicious areas without obscuring the region of interest, enabling more accurate interpretation of mammograms and increased detection of calcifications and masses. The technology integrates several complementary algorithms and sophisticated voting methods to achieve high sensitivity and low false positive rates for greater levels of certainty.

AccuDetect reduces oversight errors, automates the comparison of historical mammograms with current mammograms (film or digital-based) and determines changes and anomalies. It easily integrates with existing analog and digital systems to improve accuracy and efficiency of data interpretation.

About Parascript, LLC

The Parascript image analysis suite extracts meaningful information from images. Employing patented digital image analysis and pattern recognition technologies, the Parascript image analysis suite improves decision quality in medical imaging, postal and payment automation, fraud detection and forms processing operations. Parascript software processes over 100 billion imaged documents per year. Fortune 500 companies, postal operators, major government and financial institutions rely on Parascript products. Organizations include the U.S. Postal Service, Bowe Bell & Howell, CheckFree, Elsag, Lockheed Martin, NCR, Siemens and Unisys. Parascript is online at http://www.parascript.com.

CONTACT: Claudette Allingham of Parascript, LLC, +1-303-381-3100,
claudette.allingham@parascript.com; or Hilary McCarthy of SZPR,
+1-508-829-2543, hilary@szpr.com, for Parascript, LLC

Web site: http://www.parascript.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES